Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Factors involved in the success of antimuscarinic treatment.

Literature DB >> 10210604

Factors involved in the success of antimuscarinic treatment.

P Abrams¹, G Larsson, C Chapple, A J Wein.

Abstract

Mesh：

Substances：

Year: 1999 PMID： 10210604 DOI： 10.1046/j.1464-410x.83.s2.3.x

Source DB: PubMed Journal: BJU Int ISSN： 1464-4096 Impact factor: 5.588

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

1. Repeated injections of intradetrusor onabotulinumtoxinA as adjunctive treatment of children with neurogenic bladder.

Authors: Cristian Sager; Carol Burek; Juan Bortagaray; Juan Pablo Corbetta; Santiago Weller; Victor Durán; Juan Carlos Lopez
Journal: Pediatr Surg Int Date: 2014-01 Impact factor: 1.827

Review 2. Botulinum toxin injections for treating neurogenic detrusor overactivity.

Authors: Ömer Bayrak; Erkan Sadioğlu; Rahmi Onur
Journal: Turk J Urol Date: 2015-12

3. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury.

Authors: Jose Ailton Fernandes Silva; Marcia de Castro Diniz Gonsalves; Rogerio Teles de Melo; Fabricio Borges Carrerette; Ronaldo Damião
Journal: World J Urol Date: 2014-02-27 Impact factor: 4.226

4. [Overactive bladder--which diagnosis investigations are necessary before initiating primary treatment?].

Authors: B Schönberger
Journal: Urologe A Date: 2003-04-25 Impact factor: 0.639

5. Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.

Authors: Steven E Swift; Paul Siami; Sergio Forero-Schwanhaeuser
Journal: Clin Drug Investig Date: 2009 Impact factor: 2.859

Factors involved in the success of antimuscarinic treatment.

1. Repeated injections of intradetrusor onabotulinumtoxinA as adjunctive treatment of children with neurogenic bladder.

Review 2. Botulinum toxin injections for treating neurogenic detrusor overactivity.

3. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury.

4. [Overactive bladder--which diagnosis investigations are necessary before initiating primary treatment?].

5. Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.

6. Pharmacotherapy in pediatric neurogenic bladder intravesical botulinum toxin type a.

Review 7. Overactive bladder: strategies to ensure treatment compliance and adherence.

8. Adherence to antimuscarinics in children with overactive bladder.